𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Reversible hyperkinesia in a patient with autoimmune polyglandular syndrome type I

✍ Scribed by Baumert, T. ;Kleber, G. ;Schwarz, J. ;St�bler, A. ;Lamerz, R. ;Mann, K.


Publisher
Springer-Verlag
Year
1993
Tongue
English
Weight
554 KB
Volume
71
Category
Article
ISSN
1432-1440

No coin nor oath required. For personal study only.

✦ Synopsis


Autoimmune polyglandular syndrome is characterized by a failure of multiple endocrine organs and the presence of circulating organ-specific autoantibodies targeted against the failing organs. Here we describe a patient with autoimmune polyglandular syndrome type I with the endocrine manifestations of hypoparathyroidism, adrenocortical insufficiency, and insulin-dependent diabetes mellitus. Long-standing hypoparathyroidism led to extensive calcification of the basal ganglia which resulted in the clinical presentation of an extrapyramidal movement disorder (choreoathetotic and hemiballistic hyperkinesia of the left extremities). Interestingly, parallel to rehydration and the initiation of cortisol replacement therapy a complete reversion of the hyperkinetic signs was achieved. This case shows a rare multiendocrine organ failure with complex metabolic interactions resulting in marked neurological signs. Furthermore, this case demonstrates for the first time that a hyperkinetic syndrome--most likely due to hypoparathyroidism-induced basal ganglia calcification--can be reversed solely by adequate treatment of the concomitant endocrine failures.


📜 SIMILAR VOLUMES


Autoantibodies in autoimmune polyglandul
✍ Sergueï O. Fetissov; Sophie Bensing; Jan Mulder; Erwan Le Maitre; Anna-Lena Hult 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 321 KB

## Abstract Patients with autoimmune polyglandular syndrome type I (APS1) often display high titers of autoantibodies (autoAbs) directed against aromatic L‐amino acid decarboxylase (AADC), tyrosine hydroxylase (TH), tryptophan hydroxylase (TPH), and glutamic acid decarboxylase (GAD). Neurological s

Autoantibodies in autoimmune polyglandul
✍ Sergueï O. Fetissov; Sophie Bensing; Jan Mulder; Erwan Le Maitre; Anna-Lena Hult 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB

## Abstract Patients with autoimmune polyglandular syndrome type I (APS1) often display high titers of autoantibodies (autoAbs) directed against aromatic L‐amino acid decarboxylase (AADC), tyrosine hydroxylase (TH), tryptophan hydroxylase (TPH), and glutamic acid decarboxylase (GAD). Neurological s

Linkage analysis in a large kindred with
✍ Butler, Merlin G. ;Hodes, M. E. ;Conneally, P. M. ;Biegel, Angenieta A. ;Wright, 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 317 KB 👁 3 views

Schmidt syndrome (PGA syndrome type 11) is a rare condition characterized by polyglandular failure. It is an autosomal dominant trait with variable expressivity that was inherited over four generations in an Indiana kindred. Association of HLA-B8 has been reported with Schmidt syndrome. Our proband

Type I diabetes mellitus in a patient wi
✍ Elder, Deborah A. ;Kaiser-Rogers, Kathleen ;Aylsworth, Arthur S. ;Calikoglu, Ali 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 2 views

We describe a patient with type I diabetes, clinical ®ndings consistent with velocardiofacial syndrome, and a chromosome 22q11.2 deletion. A nine-year-old boy presented with a history of polyuria, polydipsia, weight loss, hyperglycemia, ketosis, serum insulin antibodies, and a low C-peptide level. H